I European Congress on Myocardial and Pericardial Diseases Resources

Read the final programme and discover the 56 abstracts presented during the meeting.

Mark you calendar!

The next annual meeting of the working group will be held in Florence, Italy on 26-28 September 2012.

Thursday 13 October

Introduction to the Cardiomyopathies:
Chairpersons: Hugo Madeira, Philippe Charron

• Basic concepts, William McKenna

• Classification, Perry Elliott

Dilated Cardiomyopathies: perspectives and challenges
Chairpersons: Eloisa Arbustini, Zofia Bilinska

• Familial dilated cardiomyopathy: still clinical phenotype and not genotype for clinical decisions?, Jens Mogensen

• Laminopathies: lessons from animal and in vitro experiments, Yigal Pinto

• Peripartum cardiomyopathy: a new familial disease?, Elisabete Martins

• Diagnostic and prognostic value of cardiac magnetic resonance imaging in dilated cardiomyopathies, James Moon

• Clinical case, Ricardo Gil

Dilated Cardiomyopathies: trends in contemporary treatment
Chairpersons: Luigi Tavazzi, Alida Caforio

• Neurohormonal blockade, yes…but how?, Cândida Fonseca

• Don’t go so fast, don’t go so slow, you will only beat, the way I show (or the case for ivabradine), J. Silva-Cardoso

• Can early ventricular resynchronization stop heart failure progression? , Francisco Morgado
• How to prevent the deleterious effects of ICD therapy in cardiomyopathies? , João de Sousa
• Clinical case, Nuno Cortez-Dias

Rare diseases
Chairpersons: Yigal Pinto, William McKenna

• Networks for Rare Diseases in Europe,  Iacopo Olivotto

• RAS-MAPK disease, Giuseppe Limongelli
• Dystrophinopathies, Eloisa Arbustini
• Metabolic diseases and the heart, Perry Elliott

Friday 14 October

Myocarditis / Pericarditis: state of the art
Chairpersons: Sabine Pankuwei, Heinz-Peter Schultheiss

• Management of pericardial effusion and cardiac tamponade: preliminary results of the

• Pan-European survey 2010-2011 , Arsen Ristic

• Diagnostic challenges and contemporary treatment of constrictive pericarditis , Petar Seferovic
• State of the art in the diagnosis of acute myocarditis,  Bernhard Maisch
• Antiviral and immunomodulation in myocarditis, Heinz-Peter Schultheiss
• Clinical case, Pedro Carrilho-Ferreira

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC):
from genetic basis to clinical diagnosis and treatment
Chairpersons: Andre Keren, Juan Ramon Gimeno

• Clinical genetics and phenocopies of ARVC an update,  William McKenna

• Molecular pathogenesis ,  Cristina Basso
• Clinical diagnosis: current limitations and new perspectives,  António Freitas
• Anti-arrhythmic drugs, catheter ablation, ICD: choice or sequence? , Pier Lambiase
• Clinical case , Miguel Ventura

Ethical and practical issues in the management of patients with cardiomyopathies
Chairpersons: Paolo Spirito, Jens Mogensen

• Should all patients with cardiomyopathy be offered clinical and genetic testing?, Philippe Charron

• Practical organization of family screening in relatives , Tiina Helio

Would you please show me?
Chairpersons: Lorenzo Monserrat, Arsen Ristic

• How to diagnose Restrictive Cardiomyopathy?, Andre Keren

• How successful is enzyme replacement therapy in Anderson-Fabry disease? , Ales Linhart
• How careful must we be before diagnosing Left Ventricle non-compaction? , Antonis Pantazis
• How to diagnose cardiac Amyloidosis? , Claudio Rapezzi
• How to understand Tako-Tsubo Cardiomyopathy ,  Birke Schneider

Revealing the secrets of the hypertrophic left ventricle…
Chairpersons: Hugo Madeira, Ales Linhart

• HCM phenocopies: and I still haven’t found what I am looking for... , Nuno Cardim

• Athlete’s heart or hypertrophic cardiomyopathy: a never ending story?, Aris Anastazakis
• Malignant mutations in hypertrophic cardiomyopathy: evidence or lack of evidence? , Dulce Brito
• Imaging and the risk for sudden death: what we know and what we don’t know , Lorenzo Monserrat
• Clinical case , Olga Azevedo

Treatment of hypertrophic cardiomyopathy: alleviating symptoms or changing the natural history of the disease?
Chairpersons: Hubert Seggewiss, Tiina Helio

• Best use of conventional medical treatment: beta-blockers, calcium channel blockers

• and disopyramide? , Paolo Spirito

• From rational concepts to clinical evidence: neurohormonal and metabolic modulation?,  Perry Elliott
• Electrical devices in HCM: ICD alone? What about CRT? Still a role for DDD? , Enrique Galvé
• Alcohol septal ablation and Morrow´s surgery: allies or competitors?, Juan Ramon Gimeno
• Clinical case , Marisa Trabulo

Saturday 15 October

Pathways for the future
Chairpersons:  Luigi Tavazzi, Philippe Charron

• Registries for cardiomyopathies. Lessons and pitfalls, Perry Elliott

• From cardiomyopathy centres to inherited cardiovascular disease centres ,  Eloisa Arbustini
• Development of new diagnostic criteria in myocarditis - The working group “Position Statement”, Alida Caforio

The best posters session. Presentations
Chairpersons: Hubert Seggewiss, Iacopo Olivotto
Jury: Eloisa Arbustini, Luigi Tavazzi, William McKenna

• Clinical significance of giant negative T-waves in patients with tako-tsubo cardiomyopathy, Birke Schneider

• Is Beta-Blocker treatment able to prevent the occurrence of stress cardiomyopathy? , Birke Schneider

• Surgical correction of HOCM in patients with extreme hypertrophy and septal myocardial fibrosis, Konstantin Borisov

• Hypertrophic cardiomyopathy: clinical aspectos of 7 novel missense mutations in MYBPC3 gene, Dulce Brito

• Lamin A/C mutations are a novel and independent risk factor for thromboembolic complications, Ingrid A.W. van Rijsingen

• Prediction of response to cardiac resynchronization therapy in patients with non-ischaemic dilated cardiomyopathy, T. Vaikhanskaia

Congress summing-up: the main messages

• Myocarditis/Pericarditis,  Petar Seferovic
• Rare cardiomyopathies, Andre Keren
• Arrhythmogenic cardiomyopathy , William McKenna
• Dilated cardiomyopathy ,  Hugo Madeira
• Hypertrophic cardiomyopathy,  Perry Elliott